Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
07:04 *Aegon mikt op kapitaalgeneratie van circa 1,2 miljard euro 07:04 *Aegon mikt op vrije kasstroom van circa 0,8 miljard euro 07:04 *Aegon mikt op dividend per aandeel van 0,40 euro 07:04 *Doelen Aegon gelden per 2025
Ter info part 1Capital Markets Day 2023: Transforming Aegon – The Next Chapter Thu, June 22, 2023 at 7:00 AM GMT+2Aegon to accelerate its strategy to create leading businesses in investment, protection and retirement solutions Transamerica, Aegon’s US subsidiary, to accelerate growth and build America’s leading middle market life insurance and retirement company Aegon on track to close a.s.r. transaction in the coming weeks and start associated share buyback Strategy execution and active capital management to create significant financial flexibility at the holding company Aegon will adapt its operating model to align with business profile; refreshed logo marks the next chapter in Aegon’s transformation and its sharpened operating model New chapter in strategy expected to lead to increase in operating capital generation from units to around EUR 1.2 billion, free cash flow to around EUR 800 million and dividend per share to EUR 0.40 by 2025 The Hague, June 2022, 2023 - Aegon’s ambition is to build leading businesses offering customers investment, protection and retirement solutions. Today, Aegon presents the next chapter of this transformation. Aegon CEO, Lard Friese, will be joined by CFO Matt Rider, Duncan Russell, Chief Transformation Officer, Will Fuller, CEO of Transamerica – Aegon’s largest business unit – and other members of the management team of Transamerica to outline their plans to create value. The event, entitled “Transforming Aegon – The Next Chapter,” follows the successful execution of the first phase of the company’s transformation that was announced at Aegon’s 2020 Capital Markets Day (CMD). Aegon CEO, Lard Friese, commented: “Today, Aegon is a more focused company with improved operational performance, a stronger balance sheet, and an enhanced risk profile. We have delivered on the plans outlined at our last Capital Markets Day. The transaction to combine Aegon’s Dutch pension, life and non-life insurance, banking, and mortgage origination activities with a.s.r. closes off the first chapter of Aegon’s transformation and enables us to accelerate the execution of our strategy. “At today’s CMD, we will outline the steps we are taking to ensure that Transamerica, our US subsidiary, captures its full potential. Transamerica has had a long and proud history of making financial services available to the many, not just the few. We aim to accelerate Transamerica’s growth and build America’s leading middle market life insurance and retirement company. This rapidly growing market, representing 68 million middle income households, is the largest in the US and is relatively underserved by the financial services industry. Transamerica is well positioned to grow and to capture the opportunities in this market,” said Lard Friese. Transamerica’s strategy consists of four focus areas. First, Transamerica will invest further in World Financial Group (WFG), its insurance distribution network of around 70,000 independent agents. WFG distributes Transamerica products, as well as those of other insurers. Its distinctive, nationwide network is the third largest agency force in the United States and the largest in Canada. WFG’s agents come from a wide range of diverse cultural backgrounds, and meet the needs of the communities in which they operate. Transamerica’s ambition is to increase the number of WFG agents to 110,000 by 2027, while at the same time improving agent productivity. Second, Transamerica will invest in its product manufacturing capabilities and operating model in order to provide an improved and differentiated customer experience and to support sales growth. It will insource and redesign critical operational and administrative functions, including core customer services, that are currently managed by an external provider. As a result, Transamerica will be well positioned to grow its life insurance business sold through both WFG and third-party distributors. Third, in Workplace Solutions, Transamerica aims to increase earnings from its retirement business which provides recordkeeping and investment services for US defined contribution plans, and advice to plan participants. With a focus on the mid-sized and pooled employer retirement plan market, Transamerica will invest to leverage its capabilities as a recordkeeper with the ambition to materially increase the penetration of the ancillary products and services it offers. In particular, it will build on its expertise in stable value investment options and individual retirement savings accounts. Fourth, Transamerica will continue to reduce its exposure to Financial Assets and improve the level and predictability of its capital generation. Since the 2020 CMD, Aegon has released USD 1.5 billion of capital from its Financial Assets in the US. Looking forward, Transamerica will expand the scope of Financial Assets to include legacy Universal Life contracts, and take additional management actions which are expected to release another USD 1.2 billion of capital in the next five years. The financial flexibility this creates will be prioritized to further reduce exposure to Financial Assets. In addition to sharing its plans for Transamerica, Aegon will provide an update on the a.s.r. transaction, which is expected to be completed in the coming weeks. Shortly after closing, Aegon expects to initiate the associated capital return of EUR 1.5 billion as announced on October 27, 2022, through a share buyback over a 12-month period. Post-closing, Aegon intends to hold its 29.99% strategic stake in a.s.r. to capture the value of cost and capital synergies associated with the integration of its former Dutch business into a.s.r. Aegon is making progress on the review of the implications of the transaction with a.s.r for group supervision. The discussions with the college of supervisors, representing all local regulators of Aegon, are ongoing and no decisions have been made. Any further details will be made available if and when appropriate. Regardless of the outcome, Aegon intends to maintain its head office in the Netherlands. Its shares will remain listed on Euronext in Amsterdam and the New York Stock Exchange.
part 2 Aegon will continue to strengthen its UK business and its fully-owned global asset manager, and to support their journeys to build leadership positions. In addition, Aegon will invest in growing its various joint ventures in Aegon International and Asset Management. In 2024, Aegon will provide an update on its plans to deliver on the full potential of these businesses. Aegon’s near-term priority in the UK is to maintain expense discipline to create room for investments, and to drive sales growth in the Retail and Workplace channels on its platform. Aegon Asset Management is in the process of completing the implementation of its global operating platform. It will continue to focus on growing in alternative asset and retirement investment solutions, and will implement additional efficiency measures. In its joint ventures, Aegon will continue to create value by using its international expertise to leverage the knowledge of the local management teams. “As part of the next chapter in our transformation, we are adapting our organization and changing the operational set-up of the holding company. The business units will focus on delivering on their strategic objectives by improving customer experience and propositions, strengthening their operations and maintaining strong controls. The holding company will set the overarching strategic direction, identify and drive business opportunities, allocate capital in a rational and disciplined manner, manage performance tightly, set the risk appetite and actively manage risk. Lastly, we will take key talent management decisions. To mark these changes and to better reflect our company’s new profile, Aegon will operate with a refreshed logo,” said Lard Friese. Financial implications and financial targets The execution of Transamerica’s strategic plan is expected to result in a significant increase of the earnings on in-force from its Strategic Assets. Transamerica plans to reinvest part of its earnings on in-force from Strategic Assets in profitable new business to secure long-term growth. This is anticipated to result in a gradual increase in operating capital generation from Strategic Assets to fund growing remittances to the Holding. Transamerica targets a mid-single digit growth rate of its remittances in the medium-term, from a level of USD 550 million in 2023. The associated investments to achieve Transamerica’s strategic ambitions are expected to have a one-time impact of -15%-points on the US RBC ratio and reduce Aegon’s equity by around USD 450 million. The majority of these impacts are expected to be incurred in the second quarter of 2023. The additional actions that Transamerica has identified to reduce its exposure to Financial Assets include the intention to remove the remaining morbidity improvement assumption and increase the inflation assumption in its Long-Term Care business. Associated with these assumption changes, Transamerica will seek approvals for additional actuarially justified premium rate increases with a combined value of USD 700 million. In addition, Transamerica will take actions to mitigate the capital volatility caused by its annuity and universal life with secondary guarantees blocks of business. These management actions are expected to have a combined one-time impact of -5%-pts on the US RBC ratio and reduce Aegon’s equity by around USD 250 million. The majority of these impacts are expected to be incurred in the second quarter of 2023. Throughout its transformation, Aegon will ensure that it maintains sufficient capital in its business units and at the Holding so that management can focus its time and energy on increasing the return on capital, and distributing capital to shareholders. In Aegon’s capital management approach, the company will continue to focus on managing the capital positions of its business units to their respective operating levels over time. For Transamerica, the operating level remains at an RBC ratio of 400%. The RBC ratio was 436% on March 31, 2023, which makes Transamerica well positioned to manage the RBC ratio to the operating level and to continue to pay its planned remittances even in the case of moderately adverse scenarios. The operating range for Cash Capital at Holding remains EUR 0.5 billion to EUR 1.5 billion. Aegon expects to reduce the Cash Capital at Holding from EUR 1.4 billion on March 31, 2023, to around the mid-point of the operating range over time. Aegon intends to do so by returning capital to shareholders in the absence of value-creating opportunities, in line with its capital management approach. As previously indicated, Aegon will reduce its gross financial leverage by up to EUR 700 million following the closing of the transaction with a.s.r., which brings it to around EUR 5.0 billion. By increasing its earnings and managing capital in a disciplined manner, Aegon expects to grow operating capital generation over the plan period and translate this into increasing free cash flow. Aegon expects its operating capital generation before holding funding and operating expenses to grow from at least EUR 1.0 billion in 2023 to around EUR 1.2 billion in 2025. Free cash flow is expected to grow in line with the anticipated growth in operating capital generation, and is anticipated to benefit from the expected growth in dividends to be received on Aegon’s strategic stake in a.s.r. As a result, Aegon expects to grow its free cash flow from around EUR 600 million in 2023 to around EUR 800 million in 2025. Dividends are expected to remain well covered by free cash flow. Furthermore, on a per share basis, dividends will benefit from the deployment of Aegon’s financial flexibility at the Holding. As a result, Aegon aims to grow its dividend per share from around EUR 0.30 over 2023 to around EUR 0.40 over 2025, barring unforeseen circumstances.
Ik krijg er geen warm gevoel bij. Weer een Nederlands bedrijf dat een Amerikaanse dochter probeert te "upgraden".
40 cent dividend, op mijn aandeeltjes van 4,01 euro per stuk. Ca. 10% dividendrendement, ik kan daar wel mee leven.
Niets verrassends en nog geen grote "andere" stappen aangekondigd, dus ik vermoed dat teleurstelling op de loer ligt n.a.v. deze "highly anticipated" beleggersdag. Dat zou kansen bieden, aangezien het wel duidelijk is dat er nog wat verborgen waarde in Aegon zit (+ de strategische mogelijkheden) en het aandeleninkoopprogramma (€1,5 mrd, te starten na de spoedig af te ronden transactie met ASR). Ik hoop dus dat beleggers zich vandaag van hun meest teleurgestelde kant laten zien; ik heb al positie, maar had wat aarzeling om samen met de kudde op voorhand door deze open deur te stappen door die positie op te leuken in anticipatie op een te voor de hand liggende euforische reactie.
Mario schreef op 22 juni 2023 07:26 :
1,5mld aandelen inkoop
Binnen 12 maanden ook nog!
Branco P schreef op 22 juni 2023 07:27 :
40 cent dividend, op mijn aandeeltjes van 4,01 euro per stuk. Ca. 10% dividendrendement, ik kan daar wel mee leven.
Zit iets onder de 4 euro kan er ook heel goed mee leven.
MOEdig Voorwaarts schreef op 22 juni 2023 07:28 :
Niets verrassends en nog geen grote "andere" stappen aangekondigd, dus ik vermoed dat teleurstelling op de loer ligt n.a.v. deze "highly anticipated" beleggersdag. Dat zou kansen bieden, aangezien het wel duidelijk is dat er nog wat verborgen waarde in Aegon zit (+ de strategische mogelijkheden) en het aandeleninkoopprogramma (€1,5 mrd, te starten na de spoedig af te ronden transactie met ASR).
Ik hoop dus dat beleggers zich vandaag van hun meest teleurgestelde kant laten zien; ik heb al positie, maar had wat aarzeling om samen met de kudde op voorhand door deze open deur te stappen door die positie op te leuken in anticipatie op een te voor de hand liggende euforische reactie.
Eerlijk gezegd denk ik dat dit een heel mooi verhaal is, kan me niet voorstellen dat dit teleurstelling opwekt op het huidige koersniveau. Flinke inkoop binnen 12 maanden, divi naar 0,4 en geen gekke beslissingen gewoon focus op uitbouwen mooie onderdelen binnen Aegon!
Mario schreef op 22 juni 2023 07:26 :
1,5mld aandelen inkoop
En dat was bij de aankondiging van de transactie in oktober 2022 ook al in het vooruitzicht gesteld:Intention to use cash proceeds to return EUR 1.5 billion capital to shareholders and reduce leverage by up to EUR 700 million consistent with disciplined capital management approach www.aegon.com/newsroom/news/press-rel... Kortom, ik blijf erbij dat deze beleggersdag vermoedelijk minder spektakel biedt dan waar belegger op hadden gehoopt/geanticipeerd.
Ongeveer 16 % van het uitstaande aandelen kapitaal wordt ingekocht. Noem dat maar niets en dat binnen 1 jaar. Volgend jaar op €7.
Aegon presenteert nieuwe doelstellingen Dividend fors omhoog. (ABM FN-Dow Jones) Aegon heeft nieuwe financiële doelstellingen gepresenteerd en verhoogde de dividendverwachting voor 2025. Dit kwam donderdag naar voren uit een persbericht in aanloop naar de beleggersdag van de verzekeraar vanmiddag in Londen. Ook bevestigde Aegon de inkoop van eigen aandelen ter waarde van 1,5 miljard euro In 2025 verwacht Aegon operationeel circa 1,2 miljard aan kapitaal te genereren, met een vrije kasstroom van ongeveer 800 miljoen euro. De vrije kasstroom komt in 2023 naar verwachting uit op 600 miljoen euro. De dividenduitkering in 2025 zal daarnaast naar verwachting uitkomen op 0,40 euro per aandeel. Over 2023 bedraagt het uit te keren dividend 0,30 euro. In 2022 was dit nog 0,23 euro per aandeel. Daarnaast ligt het bedrijf op schema om de verkoop van de Nederlandse activiteiten aan ASR Nederland af te ronden, waarna direct het inkoopprogramma van eigen aandelen van start zal gaan met een looptijd van een jaar, ter waarde van 1,5 miljard euro. Dit werd vorig jaar oktober al aangekondigd. "Aegon is tegenwoordig een meer gefocust bedrijf met verbeterde operationele prestaties, een sterkere balans en een verbeterd risicoprofiel", zei topman Lard Friese donderdag in een toelichting. "De transactie waarbij Aegon's Nederlandse activiteiten [-] samengaan met ASR sluit het eerste hoofdstuk van Aegon's transformatie af, en stelt ons in staat de uitvoering van onze strategie te versnellen." Onder meer de groei van Transamerica, de Amerikaanse dochteronderneming van Aegon, zal worden aangejaagd. Een juiste uitvoering van de strategie en actief kapitaalbeheer moet daarbij aanzienlijke financiële flexibiliteit bij de holding creëren. "Tijdens de beleggersdag van vandaag zullen we de stappen uiteenzetten die we nemen om ervoor te zorgen dat Transamerica, onze Amerikaanse dochteronderneming, zijn volledige potentieel gaat benutten", aldus Friese. Aegon wil daarbij een groei van ongeveer 5 procent van de ontvangen premies op middellange termijn realiseren. Aegon zet ook stappen om zijn Britse- en vermogensbeheer activiteiten te verstevigen. Door: ABM Financial News.info@abmfn.nl Redactie: +31(0)20 26 28 999
Snel rekenen in 52 weken komt dat op bijna 5 miljoen aandelen per werkdag!! Theoretisch natuurlijk
LTBelegger schreef op 22 juni 2023 08:01 :
Snel rekenen in 52 weken komt dat op bijna 5 miljoen aandelen per werkdag!!
1,5 miljard gedeeld door koers 5,00 is 300 miljoen aandelen gedeeld door 250 beursdagen is 1,2 stuks per dag!
Brimily schreef op 22 juni 2023 08:14 :
[...] 1,5 miljard gedeeld door koers 5,00 is 300 miljoen aandelen
gedeeld door 250 beursdagen is 1,2 miljoen stuks per dag!
LTBelegger schreef op 22 juni 2023 08:01 :
Snel rekenen in 52 weken komt dat op bijna 5 miljoen aandelen per werkdag!!
Denk iets te snel gerekend Ik kom toch tot een andere hoeveelheid: 1.500.000.000/4,40 = 341 mln / 52 = 6,5 mln / 5 = 1,3 mln per werkdag.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)